Should I prescribe Dehydroepiandrosterone (DHEA) to a patient on testosterone therapy with optimal testosterone levels but low DHEA levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DHEA Supplementation in Patients on Testosterone Therapy with Low DHEA Levels

DHEA supplementation is not recommended for patients on testosterone therapy with optimal testosterone levels but low DHEA levels, as there is insufficient evidence to support its use for improving morbidity, mortality, or quality of life outcomes in this specific population.

Current Guidelines on Testosterone Therapy

  • The goal of testosterone therapy is normalization of total testosterone levels (450-600 ng/dL) combined with improvement in symptoms or signs 1
  • Clinicians should adjust testosterone therapy dosing to achieve a total testosterone level in the middle tertile of the normal reference range 1
  • Testosterone therapy should be stopped if patients do not experience symptomatic relief after reaching target testosterone levels 1

DHEA Supplementation: Evidence and Considerations

Limited Evidence for DHEA in Men on Testosterone Therapy

  • There are no specific guidelines from the American Urological Association (AUA) recommending DHEA supplementation for men already on testosterone therapy with optimal testosterone levels 1
  • No consistent beneficial effects of DHEA supplementation have been found for men in placebo-controlled trials 2
  • DHEA is primarily marketed as a dietary supplement with limited FDA oversight and variable quality control between products 3

Potential Indications for DHEA

  • DHEA has shown some benefit primarily in women with specific conditions:
    • Women with adrenal insufficiency (30-50 mg daily) 2
    • Women over 60 years for bone mineral density 2
    • Female patients with systemic lupus erythematosus 2
    • Female patients with sexual dysfunction 4

Safety Considerations

  • Long-term effects of DHEA replacement therapy are not fully known, warranting caution 4
  • DHEA is converted into both testosterone and estradiol, which may have unintended hormonal effects 2
  • Quality control of DHEA supplements is a concern, with different brands potentially containing different amounts of active ingredient 3

Clinical Approach to Patients with Low DHEA but Optimal Testosterone

  1. Focus on optimizing current testosterone therapy

    • Ensure testosterone levels are maintained in the middle tertile of the normal reference range (450-600 ng/dL) 1
    • Continue monitoring for symptomatic improvement with current testosterone therapy 1
  2. Address lifestyle factors

    • Counsel patients that lifestyle modifications such as weight management and increased physical activity can improve testosterone levels and reduce symptoms 1
    • High body mass index coupled with low testosterone increases cardiovascular risk 1
  3. Consider other causes of persistent symptoms

    • If erectile dysfunction persists despite optimal testosterone levels, consider PDE5 inhibitors 1
    • Evaluate for other potential causes of fatigue, low energy, or mood issues beyond hormonal factors 5

Common Pitfalls to Avoid

  • Assuming that normalizing all hormone levels (including DHEA) is necessary when testosterone is already optimized 5, 6
  • Relying on animal studies for DHEA benefits, as DHEA is essentially a human molecule with different effects across species 5
  • Overlooking the variable quality and potency of over-the-counter DHEA supplements 3
  • Failing to recognize that DHEA's effects in humans are primarily through its conversion to testosterone and estradiol, which may be redundant in patients already on testosterone therapy 6

In conclusion, while DHEA supplementation has shown benefits in specific populations (primarily women with certain conditions), there is insufficient evidence to recommend its use in men who are already on testosterone therapy with optimal testosterone levels but low DHEA levels.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Androgen therapy with dehydroepiandrosterone.

World journal of urology, 2003

Research

DHEA supplementation: the claims in perspective.

Cleveland Clinic journal of medicine, 2005

Guideline

DHEA Supplementation for Female Sexual Dysfunction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

DHEA treatment: myth or reality?

Trends in endocrinology and metabolism: TEM, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.